35.07 -0.30(-0.85%)10/04/2024
PTC Therapeutics Inc (PTCT)
PTC Therapeutics Inc (PTCT)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| 3 Top Stocks That Could Still Rocket Higher in 2024 | 10/04 05:17 | fool.com |
| PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients | 10/01 09:00 | prnewswire.com |
| FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program | 09/26 08:00 | prnewswire.com |
| PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 09/12 16:30 | prnewswire.com |
| PTC Therapeutics: Positive HD Data Along With NDA Submission Brings Further Value | 09/12 16:13 | seekingalpha.com |
| PTC Therapeutics to Participate at Upcoming Investor Conferences | 08/28 16:30 | prnewswire.com |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT | 08/11 10:00 | accesswire.com |
| PTC Therapeutics, Inc. (PTCT) Q2 2024 Earnings Call Transcript | 08/09 11:53 | seekingalpha.com |
| PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates | 08/08 18:20 | zacks.com |